Clinicians' Biosecurity News Archive: 2017
- 12-01-2017: The Role of Parainfluenza Viruses in Severe Respiratory Infections A new study suggests that parainfluenza viruses might play a most important role in serious illness than previously recognized.
- 11-17-2017: Herd Immunity: Keeping Zika at Bay, For Now Zika infection rates appear to have ebbed, a new study reveals that Zika’s extraordinary trajectory may explain its diminished ability to cause new infections.
- 11-01-2017: The Ascent of H7N9 The H7N9 avian influenza virus has now caused more human cases than H5N1 and tops CDC’s list of potential pandemic threats.
- 10-20-2017: Anticipating a Severe Flu Season While the flu season in this hemisphere has yet to fully commence, there are important signals that it may be severe.
- 09-29-2017: Critical Illness and MERS A new retrospective multicenter cohort study focused on critically ill MERS patients in Saudi Arabia and provides important information.
- 09-15-2017: The Risks and Benefits of Repeated First Trimester Influenza Vaccination Against Pandemic H1N1 We put in context a new study showing an association between first trimester pH1N1 vaccination and miscarriage.
- 08-28-2017: What Sandy teaches us about Harvey We summarize our studies of the impact of Hurricane Sandy on the health sector of greater New York and its valuable lessons for Hurricane Harvey.
- 08-18-2017: Allocating Scarce Life-Sustaining Resources in a Disaster During a catastrophe, healthcare providers may face difficult questions about who will receive limited life-saving resources.
- 08-04-2017: New Zika Testing Strategy to Avoid False Positives in Pregnant Women The discovery that IgM antibodies persist for periods longer than 12 weeks, the CDC has released new interim guidance for testing pregnant women.
- 07-14-2017: CCHF in Spain: Geographic Dynamics, Nosocomial Spread Two cases of Crimean Congo hemorrhagic fever due to an African strain were recently in Spain one of which involved nosocomial transmission.
- 06-30-2017: Combination Therapy for Lassa Fever The optimum therapy for Lassa fever is unknown. In a new uncontrolled report of 2 cases, combination therapy was used and both patients survived.
- 06-09-2017: NSAID-Macrolide-Antiviral Combination Improves Mortality in Flu results of a clinical trial that combined the NSAID naproxen and the macrolide antibiotic clarithromycin with oseltamivir and broad spectrum antibiotics.
- 05-26-2017: Asymptomatic Ebola: A Rare Event New evidence suggests that asymptomatic Ebolavirus infection occurs very rarely which has implications for epidemic preparedness and response.
- 05-12-2017: MERS Serosurveys: Waning Antibody Levels Complicate Epidemiologic Surveillance With every infectious disease, there is a spectrum of illness that can range from fulminant fatal disease to completely asymptomatic disease.
- 04-21-2017: CNS Infections in the US: Room for Improvement in Treatment Infections of the central nervous system are one of the most challenging aspects of infectious disease medicine.
- 04-07-2017: Coronavirus HKU1 Infections in Cleveland A new report reveals the incidence of coronavirus infections among a series of patients in Cleveland with respiratory infections.
- 03-03-2017: The Increasing Pandemic Potential of H7N9 Avian Influenza Recent expanded activity related to the H7N9 virus in China has become increasingly worrisome and underscores the ongoing need to continue preparedness.
- 02-17-2017: BARDA and Project Bioshield Progress Report Details Core National Security Role Project Bioshield was tasked with facilitating the development, acquisition, and stockpiling of diagnostics, vaccines, and medications against CBRN threats.
- 01-27-2017: Seoul Virus Outbreak Highlights Ongoing Risk of Zoonotic Viruses CDC has alerted clinicians about an outbreak of Seoul hantavirus in the Midwest related to home-based rat breeding.
